$2.1B Endocyte Deal a Record-Breaker

Posted: Updated:
(Image courtesy of Endocyte) (Image courtesy of Endocyte)
WEST LAFAYETTE -

A veteran of Indiana's life sciences industry says the proposed blockbuster sale of West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is good for the ecosystem in the state. Switzerland-based Novartis AG has signed an agreement to acquire Endocyte for $2.1 billion, which BioCrossroads Project Director Brian Stemme says is "by far" the largest-ever acquisition of an Indiana life sciences company. The deal still faces regulatory and shareholder hurdles.

In an interview with Inside INdiana Business, Stemme said the deal is validation of more than 20 years of support and determination. The company was born in the mid-1990s from biotechnology developed at Purdue University by eventual founder Philip Low and fellow biochemist Christopher Leamon. Low serves as chief science officer and Leamon is vice president of research and development.

"There's been just a lot of people between Dr. Low, Purdue University, the state of Indiana, all the executives and scientists that have been supporting that company over the years, so to see it really be recognized and work with a company that can help get that product to market, it's exciting," Stemme said. "It's a validation that all those folks knew what they were doing, knew what they were talking about, they saw the promise of that technology early and then just kept on grinding."

Stemme says the deal adds to some $8 billion in transactions involving Hoosier life sciences businesses in the last five years, including:

Endocyte is based at Purdue Research Park in West Lafayette, and last month, it was recognized as the first Purdue startup to be valued at $1.5 billion. Purdue President Mitch Daniels says "the sale of Endocyte is a landmark moment, but given the explosion in entrepreneurship and new start-ups at Purdue, I'm sure it's the first of many to come. "We are so deeply proud of our Purdue scientists whose genius is saving lives from cancer, and now has brought great new wealth to Indiana."

Last year, the company acquired a promising prostate cancer therapy in the late stages of development from ABX GmbH in Germany. Endocyte says it expects the acquisition will boost the chances of PSMA-617 going to market. Endocyte went public in 2011, raising $79 million during its initial public offering.

BioCrossroads Project Director Brian Stemme said the deal is validation of more than 20 years of support and determination.
  • Perspectives

    • Indiana's Regrettable Struggle to Pass Hate Crime Legislation

      It shouldn’t be this hard. The Senate’s Public Policy Committee voted 9-1 in favor of SB-12 this week, a bill that would have codified (as written) hate crime bias to include protections for race, religion, color, sex, gender identity, disability, national origin, ancestry, sexual orientation, and age. SB-12 then made its way to the full Senate. Preceded by a lengthy deliberation by the Senate’s Republican caucus, the Senate voted 33-16 in favor of a watered-down...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Scotty McCreery will perform at Elkhart’s Lerner Theater on Idea Week’s Elkhart Day.

      Country Singer Joins Idea Week Line Up

      The University of Notre Dame has announced a new act joining this year's Idea Week innovation festival. The award-winning country singer got his start by winning “American Idol” in 2011. 

    • Indiana's Regrettable Struggle to Pass Hate Crime Legislation

      It shouldn’t be this hard. The Senate’s Public Policy Committee voted 9-1 in favor of SB-12 this week, a bill that would have codified (as written) hate crime bias to include protections for race, religion, color, sex, gender identity, disability, national origin, ancestry, sexual orientation, and age. SB-12 then made its way to the full Senate. Preceded by a lengthy deliberation by the Senate’s Republican caucus, the Senate voted 33-16 in favor of a watered-down...

    • New Leader Aims to Expose International School's Assets

      The new head of school at the International School of Indiana says she wants to build on 25 years of growth. Elizabeth Head, who became the school’s first female leader last month, says the school’s reputation for contributing to the workforce and attracting talent from around the world excited her about the job. She says the ISI is the only school of its kind not just in Indiana, but throughout the Midwest. In an interview on Inside INdiana Business with Gerry Dick...

    • Indiana is one of five states without a specific hate crimes law.

      Senate Passes Amended Hate Crimes Bill

      The Indiana Senate has passed a hate crimes bill, which includes a controversial amendment approved Wednesday in committee. The bill, which no longer includes a list of targeted groups, was approved by a vote of 39-10. The bill now includes a line stating criminal sentences can be lengthened for reasons "including bias."

    • Indiana Rural School Clinic Network Expands to Pekin

      East Washington School Corp. has announced that East Washington Elementary School is now a participant in the Indiana Rural School Clinic Network. Supported by Ascension/St. Vincent Salem, the school now has a telehealth clinic available to its students and staff.